A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | ZC | CHARACTERIZATION OF A NEW SIGNALING PATHWAY INVOLVED IN THE NEUTROPHIL NADPH OXIDASE REGULATION VIA S100A8/A9 TRANSLOCATION | Schenten V., Melchior C., Steinckwich N., Tschirhart EJ, Brechard S. | | CHARACTERIZATION OF THE VASOACTIVE PROPERTIES OF FINGOLIMOD AND DERIVATIVES | van den Akker RBP., Spijkers LJA., Jongsma M., van Loenen PB., Peters SLM., Alewijnse AE. | | CHEMOTACTIC COLLEGEN BREAKDOWN PRODUCT, PROLINE-GLYCINE-PROLINE, IS INVOLVED IN INFLAMMATORY BOWEL DISEASES: FUTURE TARGET? | Koelink PJ., Overbeek SA., Braber S., Morgan ME., Henricks PA., Verspaget HW., Jackson PL., Blalock JE., Folkerts G., Kraneveld AD. | | CIGARETTE SMOKE INDUCES RELEASE OF TGF-BETA IN AIRWAYS AND MODULATES TRYPTASE EXPRESSION AND MAST CELL MATURATION | Mortaz E., Givi ME., Ghahferokhi SE., Blokhuis B., Da Silva CA., Folkerts G., Redegeld FA. | | CLINICAL PHARMACOLOGY OF PURINES: FROM FOREARM TO HEART | Rongen GA., Mohammadi S., Garjani A., Najafi M., Hamzeiy H., Maleki-Dizaji N., Omidi Y., Barar J., Darabi M., Hassanzadeh K., Asadi M., Khani S. | | CONGENITAL NEPHROGENIC DIABETES INSIPIDUS: DO PHARMACOCHAPERONES PROVIDE THE CURE? | Deen PMT., Plancon S., Ritt C., Tschirhart E.J. | | CONSTRUCTING CELL LINE AND EXPERIMENT SPECIFIC GENE REGULATORY NETWORKS BY COMBINING GENERAL AND SPECIFIC MICRO ARRAY DATA | | | COPD MANAGEMENT IN PRIMARY CARE: AN OBSERVATIONAL COMMUNITY PHARMACY-BASED STUDY | Mehuys E., Boussery K., Van Bortel L., De Bolle L., Van Tongelen I., Remon J-P., Brusselle G. | | CROSS-TALK BETWEEN 7TM-RECEPTORS FOR VASOACTIVE PEPTIDES | De Mey J., Kaetzel T., Tolle F., Bueb J-L., Sauter T. | |
|